These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10124787)

  • 1. The instrumental role of product information: a study of warning labels for non-prescription drugs.
    Discenza R; Ferguson JM
    Health Mark Q; 1992; 10(1-2):155-68. PubMed ID: 10124787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing the odds of patient compliance through prescription warning labels.
    Ferguson JM; Discenza R; Miller JA
    J Health Care Mark; 1987 Mar; 7(1):37-46. PubMed ID: 10281382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of bilingual product information labels on Spanish-speaking adults' ability to comprehend OTC information.
    Sansgiry SS; Chanda S; Shringarpure GS
    Res Social Adm Pharm; 2007 Dec; 3(4):410-25. PubMed ID: 18082876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigative model evaluating how consumers process pictorial information on nonprescription medication labels.
    Sansgiry SS; Cady PS
    Health Mark Q; 1997; 14(4):71-90. PubMed ID: 10168485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warnings on alcohol containers and advertisements: international experience and evidence on effects.
    Wilkinson C; Room R
    Drug Alcohol Rev; 2009 Jul; 28(4):426-35. PubMed ID: 19594797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance, behavior change, and weight loss with orlistat in an over-the-counter setting.
    Schwartz SM; Bansal VP; Hale C; Rossi M; Engle JP
    Obesity (Silver Spring); 2008 Mar; 16(3):623-9. PubMed ID: 18239553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
    Frueh FW; Amur S; Mummaneni P; Epstein RS; Aubert RE; DeLuca TM; Verbrugge RR; Burckart GJ; Lesko LJ
    Pharmacotherapy; 2008 Aug; 28(8):992-8. PubMed ID: 18657016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration].
    Baumann M; Trincard M
    Encephale; 2002; 28(5 Pt 1):389-96. PubMed ID: 12386539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug safety labeling for doctors.
    Hecht A
    FDA Consum; 1979 Oct; 13(8):12-3. PubMed ID: 10309108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Nutrient Content and Other Label Information for Prescription Prenatal Supplements Different from Nonprescription Products?
    Saldanha LG; Dwyer JT; Andrews KW; Brown LL; Costello RB; Ershow AG; Gusev PA; Hardy CJ; Pehrsson PR
    J Acad Nutr Diet; 2017 Sep; 117(9):1429-1436. PubMed ID: 28571654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of geriatric information on the drug label for commonly prescribed drugs in older people.
    Steinmetz KL; Coley KC; Pollock BG
    J Am Geriatr Soc; 2005 May; 53(5):891-4. PubMed ID: 15877571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reading about over-the-counter medications.
    Nabors LA; Lehmkuhl HD; Parkins IS; Drury AM
    Issues Compr Pediatr Nurs; 2004; 27(4):297-305. PubMed ID: 15764435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstruction of critical information on over-the-counter medication packages by external tags.
    Sansgiry SS; Pawaskar MD
    Ann Pharmacother; 2005 Feb; 39(2):249-54. PubMed ID: 15644473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-centered approach for improving prescription drug warning labels.
    Webb J; Davis TC; Bernadella P; Clayman ML; Parker RM; Adler D; Wolf MS
    Patient Educ Couns; 2008 Sep; 72(3):443-9. PubMed ID: 18644691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpretations of a teratogen warning symbol.
    Daniel KL; Goldman KD; Lachenmayr S; Erickson JD; Moore C
    Teratology; 2001 Sep; 64(3):148-53. PubMed ID: 11514945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polypharmacy, compliance and non-prescription medication in patients with cardiovascular disease in Germany].
    Rottlaender D; Scherner M; Schneider T; Erdmann E
    Dtsch Med Wochenschr; 2007 Jan; 132(4):139-44. PubMed ID: 17230328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication use among children <12 years of age in the United States: results from the Slone Survey.
    Vernacchio L; Kelly JP; Kaufman DW; Mitchell AA
    Pediatrics; 2009 Aug; 124(2):446-54. PubMed ID: 19651573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is prescription labeling communicating to doctors about hepatotoxic drugs? A study of FDA approved product labeling.
    Willy ME; Li Z
    Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):201-6. PubMed ID: 15255086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labeling information on nonprescription drug products.
    Am Pharm; 1988 Nov; NS28(11):24-5. PubMed ID: 3207092
    [No Abstract]   [Full Text] [Related]  

  • 20. Reactions of young adult smokers to warning labels on cigarette packages.
    O'Hegarty M; Pederson LL; Nelson DE; Mowery P; Gable JM; Wortley P
    Am J Prev Med; 2006 Jun; 30(6):467-73. PubMed ID: 16704939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.